Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / why is heart disease focused milestone pharmaceutica mwn benzinga

MIST - Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today? | Benzinga

December, 26 2023 02:53 PM Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc (NASDAQ: MIST) announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered etripamil nasal spray for paroxysmal supraventricular tachycardia (PSVT).

Upon preliminary review, the FDA determined that the NDA, submitted in October 2023, was ...

Full story available on Benzinga.com

Stock Information

Company Name:	Milestone Pharmaceuticals Inc.
Stock Symbol:	MIST
Market:	NYSE
Website:	milestonepharma.com

MIST MIST Quote MIST Short MIST News MIST Articles MIST Message Board

Get MIST Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.